Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.

Thomas J, Fermé C, Noordijk EM, Morschhauser F, Girinsky T, Gaillard I, Lugtenburg PJ, André M, Lybeert MLM, Stamatoullas A, Beijert M, Hélias P, Eghbali H, Gabarre J, van der Maazen RWM, Jaubert J, Bouabdallah K, Boulat O, Roesink JM, Christian B, Ong F, Bordessoule D, Tertian G, Gonzalez H, Vranovsky A, Quittet P, Tirelli U, de Jong D, Audouin J, Aleman BMP, Henry-Amar M.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1133-1145. doi: 10.1016/j.ijrobp.2017.10.015. Epub 2017 Oct 27.

PMID:
29229324
2.

Circadian rhythm of blood cardiac troponin T concentration.

Fournier S, Iten L, Marques-Vidal P, Boulat O, Bardy D, Beggah A, Calderara R, Morawiec B, Lauriers N, Monney P, Iglesias JF, Pascale P, Harbaoui B, Eeckhout E, Muller O.

Clin Res Cardiol. 2017 Dec;106(12):1026-1032. doi: 10.1007/s00392-017-1152-8. Epub 2017 Aug 30.

PMID:
28856443
3.

Performance of highly sensitive cardiac troponin T assay to detect ischaemia at PET-CT in low-risk patients with acute coronary syndrome: a prospective observational study.

Morawiec B, Fournier S, Tapponnier M, Prior JO, Monney P, Dunet V, Lauriers N, Recordon F, Trana C, Iglesias JF, Kawecki D, Boulat O, Bardy D, Lamsidri S, Eeckhout E, Hugli O, Muller O.

BMJ Open. 2017 Jul 10;7(7):e014655. doi: 10.1136/bmjopen-2016-014655.

4.

Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Aparicio T, Gargot D, Teillet L, Maillard E, Genet D, Cretin J, Locher C, Bouché O, Breysacher G, Seitz JF, Gasmi M, Stefani L, Ramdani M, Lecomte T, Auby D, Faroux R, Bachet JB, Lepère C, Khemissa F, Sobhani I, Boulat O, Mitry E, Jouve JL; FFCD 2001-02 investigators.

Eur J Cancer. 2017 Mar;74:98-108. doi: 10.1016/j.ejca.2016.09.029. Epub 2016 Nov 5.

PMID:
27825697
5.

A Population-Based Model to Consider the Effect of Seasonal Variation on Serum 25(OH)D and Vitamin D Status.

Vuistiner P, Rousson V, Henry H, Lescuyer P, Boulat O, Gaspoz JM, Mooser V, Vollenweider P, Waeber G, Cornuz J, Paccaud F, Bochud M, Guessous I.

Biomed Res Int. 2015;2015:168189. doi: 10.1155/2015/168189. Epub 2015 Sep 1.

6.

Serum Vitamin D Concentrations Are Not Associated with Insulin Resistance in Swiss Adults.

Marques-Vidal P, Vollenweider P, Guessous I, Henry H, Boulat O, Waeber G, Jornayvaz FR.

J Nutr. 2015 Sep;145(9):2117-22. doi: 10.3945/jn.115.211763. Epub 2015 Jul 15.

PMID:
26180247
7.

Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.

Guessous I, McClellan W, Kleinbaum D, Vaccarino V, Hugues H, Boulat O, Marques-Vidal P, Paccaud F, Theler JM, Gaspoz JM, Burnier M, Waeber G, Vollenweider P, Bochud M.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1162-9. doi: 10.2215/CJN.04960514. Epub 2015 Apr 21.

8.

Admissions of patients with alcohol intoxication in the Emergency Department: a growing phenomenon.

Bertholet N, Adam A, Faouzi M, Boulat O, Yersin B, Daeppen JB, Clerc D.

Swiss Med Wkly. 2014 Aug 7;144:w13982. doi: 10.4414/smw.2014.13982. eCollection 2014.

9.

Trace element monitoring in the ICU: quality and economic impact of a change in sampling practice.

Gagnon G, Voirol P, Soguel L, Boulat O, Berger MM.

Clin Nutr. 2015 Jun;34(3):422-7. doi: 10.1016/j.clnu.2014.04.012. Epub 2014 May 9.

PMID:
24912865
10.

Analysis and quantification of vitamin D metabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry--a method comparison and validation.

Bruce SJ, Rochat B, Béguin A, Pesse B, Guessous I, Boulat O, Henry H.

Rapid Commun Mass Spectrom. 2013 Jan 15;27(1):200-6. doi: 10.1002/rcm.6439.

PMID:
23239334
11.
12.

Sensitive determination of D-lactic acid and L-lactic acid in urine by high-performance liquid chromatography-tandem mass spectrometry.

Henry H, Marmy Conus N, Steenhout P, Béguin A, Boulat O.

Biomed Chromatogr. 2012 Apr;26(4):425-8. doi: 10.1002/bmc.1681. Epub 2011 Aug 12.

PMID:
21842515
13.

Oral vitamin B12 for patients suspected of subtle cobalamin deficiency: a multicentre pragmatic randomised controlled trial.

Favrat B, Vaucher P, Herzig L, Burnand B, Ali G, Boulat O, Bischoff T, Verdon F.

BMC Fam Pract. 2011 Jan 13;12:2. doi: 10.1186/1471-2296-12-2.

14.

Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia.

Gysin R, Kraftsik R, Boulat O, Bovet P, Conus P, Comte-Krieger E, Polari A, Steullet P, Preisig M, Teichmann T, Cuénod M, Do KQ.

Antioxid Redox Signal. 2011 Oct 1;15(7):2003-10. doi: 10.1089/ars.2010.3463. Epub 2010 Oct 30.

PMID:
20673128
15.

Evidence for catabolic pathway of propionate metabolism in CNS: expression pattern of methylmalonyl-CoA mutase and propionyl-CoA carboxylase alpha-subunit in developing and adult rat brain.

Ballhausen D, Mittaz L, Boulat O, Bonafé L, Braissant O.

Neuroscience. 2009 Dec 1;164(2):578-87. doi: 10.1016/j.neuroscience.2009.08.028. Epub 2009 Aug 20.

PMID:
19699272
16.

Moderate hypercapnia exerts beneficial effects on splanchnic energy metabolism during endotoxemia.

Gnaegi A, Feihl F, Boulat O, Waeber B, Liaudet L.

Intensive Care Med. 2009 Jul;35(7):1297-304. doi: 10.1007/s00134-009-1488-2. Epub 2009 Apr 17.

PMID:
19373455
17.

Sudden unexpected death in an infant with L-2-hydroxyglutaric aciduria.

Jequier Gygax M, Roulet-Perez E, Meagher-Villemure K, Jakobs C, Salomons GS, Boulat O, Superti-Furga A, Ballhausen D, Bonafé L.

Eur J Pediatr. 2009 Aug;168(8):957-62. doi: 10.1007/s00431-008-0869-9. Epub 2008 Nov 13. Review.

PMID:
19005678
18.

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.

Lavoie S, Murray MM, Deppen P, Knyazeva MG, Berk M, Boulat O, Bovet P, Bush AI, Conus P, Copolov D, Fornari E, Meuli R, Solida A, Vianin P, Cuénod M, Buclin T, Do KQ.

Neuropsychopharmacology. 2008 Aug;33(9):2187-99. Epub 2007 Nov 14.

19.

Sulphite efflux pumps in Aspergillus fumigatus and dermatophytes.

Léchenne B, Reichard U, Zaugg C, Fratti M, Kunert J, Boulat O, Monod M.

Microbiology. 2007 Mar;153(Pt 3):905-13.

PMID:
17322211
20.

A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.

Coso D, Sebban C, Boulat O, Biron P, Rey J, Aurran T, Chabannon C, Xerri L, Chetaille B, Esterni B, Ivanov V, Stoppa AM, Schiano de Collela JM, Gastaut JA, Maraninchi D, Bouabdallah R.

Bone Marrow Transplant. 2006 Aug;38(3):217-22. Epub 2006 Jun 12.

PMID:
16770316
21.

Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial.

Panchaud A, Sauty A, Kernen Y, Decosterd LA, Buclin T, Boulat O, Hug C, Pilet M, Roulet M.

Clin Nutr. 2006 Jun;25(3):418-27. Epub 2005 Dec 2.

PMID:
16325968
22.

Increased NO production in lysinuric protein intolerance.

Mannucci L, Emma F, Markert M, Bachmann C, Boulat O, Carrozzo R, Rizzoni G, Dionisi-Vici C.

J Inherit Metab Dis. 2005;28(2):123-9.

PMID:
15877200
23.

Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.

Murati A, Arnoulet C, Lafage-Pochitaloff M, Adélaide J, Derré M, Slama B, Delaval B, Popovici C, Vey N, Xerri L, Mozziconacci MJ, Boulat O, Sainty D, Birnbaum D, Chaffanet M.

Int J Oncol. 2005 Jun;26(6):1485-92.

PMID:
15870860
24.

Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.

Thomas X, Boiron JM, Huguet F, Reman O, Sutton L, Turlure P, Garban F, Gardin C, Espinouse D, Boulat O, Lhéritier V, Fiere D; Groupe d'Etude et de Traitement de la Leucémie Aiguë Lymphoblastique de l'Adulte (GET-LALA Group).

Hematol J. 2004;5(5):384-94.

PMID:
15448664
25.

Ammonia toxicity to the brain and creatine.

Bachmann C, Braissant O, Villard AM, Boulat O, Henry H.

Mol Genet Metab. 2004 Apr;81 Suppl 1:S52-7. Review.

26.

Correlation between plasma and urine phenylalanine concentrations.

Boulos M, Boulat O, Van Melle G, Guignard JP, Matthieu JM.

Biol Neonate. 2004;86(1):6-9. Epub 2004 Jan 23.

PMID:
14739551
27.

Organic acids in the second morning urine in a healthy Swiss paediatric population.

Boulat O, Gradwohl M, Matos V, Guignard JP, Bachmann C.

Clin Chem Lab Med. 2003 Dec;41(12):1642-58.

PMID:
14708889
28.

[The pediatrician, his laboratory and its uncertainty].

Boulat O.

Rev Med Suisse Romande. 2002 Dec;122(12):645-8. Review. French.

PMID:
12611193
29.

[Ketotic hypoglycemia in children].

Matthieu JM, Boulat O.

Rev Med Suisse Romande. 2002 Dec;122(12):640-4. French.

PMID:
12611192
30.

Ammonium-induced impairment of axonal growth is prevented through glial creatine.

Braissant O, Henry H, Villard AM, Zurich MG, Loup M, Eilers B, Parlascino G, Matter E, Boulat O, Honegger P, Bachmann C.

J Neurosci. 2002 Nov 15;22(22):9810-20.

31.

Univalent salts as modifiers in micellar capillary electrophoresis.

McLaren DG, Boulat O, Chen DD.

Electrophoresis. 2002 Jun;23(12):1912-20.

PMID:
12116136
32.

Alteration of amino acid metabolism in neuronal aggregate cultures exposed to hypoglycaemic conditions.

Honegger P, Braissant O, Henry H, Boulat O, Bachmann C, Zurich MG, Pardo B.

J Neurochem. 2002 Jun;81(6):1141-51.

33.

A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia.

Bauduer F, Cousin T, Boulat O, Rigal-Huguet F, Molina L, Fegueux N, Jourdan E, Boiron JM, Reiffers J; BGMT Collaborative Group.

Leuk Lymphoma. 2001 Jul;42(3):379-86.

PMID:
11699402
34.

Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT Study Group.

Jourdan E, Reiffers J, Stoppa AM, Sotto JJ, Attal M, Bouabdallaha R, Marit G, Fégueux N, Boulat O, Dastugue N, Boiron JM, Fabères C, Gastaut JA, Maraninchi D, Blaise D; BGMT Study Group.

Leuk Lymphoma. 2001 Jun;42(1-2):57-65.

PMID:
11699222
35.

[Spinal cord compression caused by extramedullary hematopoiesis foci in the course of thalassemia].

Rey J, Gagliano R, Christides C, Pillard E, Magnan F, Tourniaire P, Arwidson I, Raymond-Gelle MC, Boulat O, Arlaud J.

Presse Med. 2001 Sep 29;30(27):1351-3. French.

PMID:
11675925
36.

[Maternal phenylketonuria].

Matthieu JM, Boulat O, Bianchi N.

Rev Med Suisse Romande. 2001 Apr;121(4):297-300. French.

PMID:
11400401
37.

[Hyperaminoaciduria in children].

Boulos M, Boulat O, Guignard JP, Matthieu JM.

Rev Med Suisse Romande. 2001 Mar;121(3):205-9. French.

PMID:
11345817
38.
39.

Difference in the homocysteine-lowering effect of folic acid in haemodialysis patients with and without occlusive vascular disease.

Descombes E, Boulat O, Bersier LF, Fellay G.

Nephrol Dial Transplant. 2001 Mar;16(3):585-9.

PMID:
11239036
40.
41.

Clinical chemistry variables in normal elderly and healthy ambulatory populations: comparison with reference values.

Boulat O, Krieg MA, Janin B, Burckhardt P, Francioli P, Bachmann C.

Clin Chim Acta. 1998 Apr 27;272(2):127-35.

PMID:
9641354
42.

Effect of L-lysine on nitric oxide overproduction in endotoxic shock.

Liaudet L, Gnaegi A, Rosselet A, Markert M, Boulat O, Perret C, Feihl F.

Br J Pharmacol. 1997 Oct;122(4):742-8.

43.

Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population.

Matos V, van Melle G, Boulat O, Markert M, Bachmann C, Guignard JP.

J Pediatr. 1997 Aug;131(2):252-7.

PMID:
9290612
44.

In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma.

Waeber G, Gomez F, Chaubert P, Temler E, Chapuis G, Boulat O, Nicod P, Haefliger JA.

Clin Endocrinol (Oxf). 1997 May;46(5):637-42.

PMID:
9231061
45.

Large deletion (7.2 kb) of mitochondrial DNA with novel boundaries in a case of progressive external ophthalmoplegia.

Hirt L, Magistretti PJ, Hirt L, Bogousslavsky J, Boulat O, Borruat FX.

J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):422-3. No abstract available.

46.

Visceral leishmaniasis and HIV-1 co-infection in southern France.

Rosenthal E, Marty P, Poizot-Martin I, Reynes J, Pratlong F, Lafeuillade A, Jaubert D, Boulat O, Dereure J, Gambarelli F, et al.

Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):159-62.

PMID:
7778140
47.

3-hydroxyisobutyric aciduria with a mild clinical course.

Boulat O, Benador N, Girardin E, Bachmann C.

J Inherit Metab Dis. 1995;18(2):204-6. No abstract available.

PMID:
7564247
48.

Automated analysis with computerized information transfer in a university hospital.

Bachmann C, Boulat O.

J AOAC Int. 1994 May-Jun;77(3):774-6.

PMID:
8012232
49.

Interleukin-2 treatment in lymphoma: a phase II multicenter study.

Gisselbrecht C, Maraninchi D, Pico JL, Milpied N, Coiffier B, Divine M, Tiberghien P, Bosly A, Tilly H, Boulat O, et al.

Blood. 1994 Apr 15;83(8):2081-5.

PMID:
8161779
50.

Pitfalls in aminoacid and organic acid analysis: 3-hydroxypropionic aciduria.

Bachmann C, Boulat O, Meyrat BJ, Colombo JP, Pilloud P.

Eur J Pediatr. 1994;153(7 Suppl 1):S23-6.

PMID:
7957382

Supplemental Content

Loading ...
Support Center